SciClone Pharmaceuticals (SCLN) Stock Analysis

What SciClone Pharmaceuticals does

SciClone Pharmaceuticals, Inc. operates as an international biopharmaceutical firm, concentrating its efforts on acquiring, advancing, and bringing to market therapeutic agents. The company's portfolio addresses a range of chronic and life-threatening ailments, such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and disorders affecting the immune system.

Key metrics

ETFs linked to SCLN

Broad-market and Healthcare sector ETFs an investor holding SciClone Pharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how SCLN fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SciClone Pharmaceuticals?

SciClone Pharmaceuticals trades under the ticker SCLN on NASDAQ.

Which exchange is SCLN listed on?

SCLN is listed on NASDAQ.

What sector does SciClone Pharmaceuticals operate in?

SciClone Pharmaceuticals is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze SCLN in a portfolio?

PortView shows SCLN's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.